Ryan Specialty Targets Modest Margin Expansion
Ryan Specialty presented a growth strategy targeting modest margin expansion.
Related stories
Sun Pharma Profit Falls on Costs Tied to Organon Deal
Sun Pharma said profit fell due to expenses related to its Organon transaction, while specialty drug sales remained solid.
M impact | EARNINGS | Oct 30, 2026, 09:19 AM UTC
Magna Beats Q3 Adjusted EPS Estimates, Raises FY Free-Cash-Flow Forecast
Magna reported Q3 adjusted EPS above estimates and raised its full-year free-cash-flow forecast.
M impact | EARNINGS | Oct 30, 2026, 09:13 AM UTC
Volkswagen Core Brand Group Reports Nine-Month Revenue of EUR106.42B
M impact | EARNINGS | Oct 30, 2026, 09:04 AM UTC
Coinbase Q3 Net Income Jumps 66% to $719 Million
Coinbase reported third-quarter net income of $719 million. Its prediction markets and derivatives businesses helped offset weaker spot trading activity, analysts said.
M impact | EARNINGS | Oct 30, 2026, 09:01 AM UTC
FTSE 100 Rises Led by Astra & BP
The FTSE 100 rose 0.5% on Friday, outperforming global markets amid a tech-led selloff, as strong earnings from heavyweight stocks AstraZeneca and BP supported the index. AstraZene
H impact | EARNINGS | Oct 30, 2026, 08:56 AM UTC
FTSE MIB Decline
Milan’s FTSE MIB fell over 1% to around 49,500 on Friday, snapping a five-day winning streak as weakness in technology stocks weighed on the index. Concerns over returns from massi
L impact | EARNINGS | Oct 30, 2026, 08:48 AM UTC